Newsroom

Up to 90% of patients treated with NMV/r face potential drug interactions.

NSAIDs should be avoided from mid-pregnancy onwards due to increased risks for the fetus.

Safe pharmacotherapy starts with the right decision. Medbase brings European experts together at EACPT 2025 to explore the future of clinical decision support

Over 95% of penicillin allergy labels are incorrect – yet millions still avoid effective treatments.

Semaglutide is unlikely to enter breast milk and was not detected in a recent study.

We are pleased to welcome Stefan Bodensteiner to Medbase as our new Sales Manager for Germany, Austria and Switzerland.

Even patients who follow their prescribed medication regimen may experience vastly different drug responses, from life-threatening adverse effects to complete lack of efficacy—highlighting the critical role of factors like drug-drug interactions, organ function, and genetic variability in treatment outcomes.

Drug interactions in older adults can lead to serious adverse events, longer hospital stays, and reduced quality of life.

Recent research indicates no evidence linking paternal valproic acid use before conception to increased risks of congenital malformations or neurodevelopmental disorders in offspring. Current data does not support major concerns.

New therapies, like SGLT2 inhibitors and GLP-1 receptor agonists, offer hope by slowing kidney disease progression and improving outcomes.

Tetracycline antibiotics can be used for up to three weeks during breast-feeding, as low milk excretion and minimal reported adverse effects have extended the recommended use.

At least one actionable pharmacogenetic mutation is present in 97-99% of population (1,2) and more than half of them had three or more mutations (2).

Ashwagandha may cause cholestatic hepatitis and elevated liver enzymes.

Drug therapies don’t always work as expected. For some patients, the drugs have no effect, while others may experience severe adverse reactions.

Markus Jansén, M.Sc. (Tech.), began his new role in April, motivated by the meaningful impact of his work.

Finland is exceptionally advanced in utilising user-friendly, high-quality drug information in everyday clinical work. This is largely due to…